About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
K
Updates From the PRIMA Trial: Niraparib as 1L Maintenance in Advanced Ovarian Cancer
By
Kenrick Ng
2 Videos
825 views
January 13, 2022
1 Comment
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
27:04
Fengting Yan
Cancer Screening Molecular Tools
06:07
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Key Updates in Gynecological Cancers"
Feat.
M. Raza Mirza
06:47
UCSF School of Medicine
Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…
Feat.
H. Kang
06:50
Fengting Yan
Year in Review: Ovarian Cancer
25:10
Yale School of Medicine
Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …
Feat.
M. Minkin,
E. Ratner
11:15
Total Health
2024 Updates in Ovarian Cancer
Feat.
T. Tillmanns
06:23
Total Health
Recent Highlights in Ovarian Cancer
Feat.
B. Slomovitz
15:14
Brian Slomovitz
Update in Vulvar and Vaginal Cancer
28:11
OncoAlert
Ovarian Cancer: Setting a New Standard of Care
Feat.
M. Raza Mirza
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
23:35
Kathleen Moore
How to Select the Best Maintenance Treatment in Patients With Ovaria…
05:32
Insights from 2023 ESMO Asia Annual Meeting
LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent…
Feat.
N. Ngoi
09:42
Erin Crane
Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer
10:27
Robert McBane
2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…
05:09
Insights from 2024 SGO Annual Meeting
SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective …
Feat.
N. Colombo
08:37
Fred Hutchinson Cancer Center
Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer: D…
Feat.
K. Banda
18:16
Insights from 2024 ESGO Annual Meeting
ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer…
Feat.
J. Kurtz
17:06
Ovarian Cancer Midwest Focus, University of Minnesota
Novel ADCs in Ovarian Cancer: A New Treatment Modality
Feat.
S. Lheureux
08:19
Insights from 2023 ESGO Annual Meeting
ESGO 2023 Insights: "Final OS and Long-Term Safety in the ENGOT…
Feat.
M. Raza Mirza
13:58
ISCO - International School of Clinical Oncology
Novel Therapies and Combinations in Ovarian Cancer
Feat.
A. Leary
